GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alphamab Oncology (HKSE:09966) » Definitions » Other Gross PPE

Alphamab Oncology (HKSE:09966) Other Gross PPE : HK$6.8 Mil (As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Alphamab Oncology Other Gross PPE?

Alphamab Oncology's Other Gross PPE for the quarter that ended in Dec. 2023 was HK$6.8 Mil.

Alphamab Oncology's quarterly Other Gross PPE increased from Dec. 2022 (HK$21.8 Mil) to Jun. 2023 (HK$661.4 Mil) but then declined from Jun. 2023 (HK$661.4 Mil) to Dec. 2023 (HK$6.8 Mil).

Alphamab Oncology's annual Other Gross PPE declined from Dec. 2021 (HK$41.3 Mil) to Dec. 2022 (HK$21.8 Mil) and declined from Dec. 2022 (HK$21.8 Mil) to Dec. 2023 (HK$6.8 Mil).

Alphamab Oncology Other Gross PPE Historical Data

The historical data trend for Alphamab Oncology's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alphamab Oncology Other Gross PPE Chart

Alphamab Oncology Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Gross PPE
Get a 7-Day Free Trial 21.90 11.64 41.27 21.83 6.79

Alphamab Oncology Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Other Gross PPE Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 41.27 675.37 21.83 661.38 6.79

Alphamab Oncology Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.

Alphamab Oncology (HKSE:09966) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alphamab Oncology (HKSE:09966) » Definitions » Other Gross PPE
Comparable Companies
HKSE:06660 HKSE:01541 HKSE:09969 HKSE:01952 HKSE:02315 HKSE:06955 HKSE:02105 HKSE:06855 HKSE:02480 HKSE:02696 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
3NK:Germany
Address
No. 175 Fangzhou Road, Suzhou Industrial Park, Jiangsu Province, Suzhou, CHN, 215024
Website
https://www.alphamabonc.com
Alphamab Oncology is a clinical-stage biopharmaceutical company in China with a fully integrated proprietary biologics platform in bispecifics and protein engineering. The company through its subsidiaries is engaged in discovery, development manufacturing and commercialization of biotherapeutics for cancer treatment.

Alphamab Oncology (HKSE:09966) Headlines

No Headlines